How many investments has UK Innovation & Science Seed Fund made?

UK Innovation & Science Seed Fund has 87 tracked investments.

What stage does UK Innovation & Science Seed Fund invest at?

UK Innovation & Science Seed Fund invests at the Pre-Seed, Seed, Series A stages.

What is UK Innovation & Science Seed Fund's typical check size?

UK Innovation & Science Seed Fund typically writes checks of $127K – $635K.

Where is UK Innovation & Science Seed Fund located?

UK Innovation & Science Seed Fund is headquartered in London, GB.

Who does UK Innovation & Science Seed Fund co-invest with?

UK Innovation & Science Seed Fund most often shares deals with Future Planet Capital, Cambridge Angels group, Oxford Investment Opportunity Network (OION), among 67 tracked co-investors.

UK Innovation & Science Seed Fund

Venture capital

London · Pre-Seed–Series A · 24 people tracked

Also known as The Rainbow Seed Fund

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into UK Innovation & Science Seed Fund

1,962 people in our graph share verified history with the UK Innovation & Science Seed Fund team — schools, employers, funds. One of them is your warm intro.

Dominic Jacquessonunlockedknows Andrew Muir · together at University of Oxford (overlapped)

×3knows the team · via The London School of Economics and Political Science (LSE)

knows the team · via University of California, Berkeley, Haas School of Business

×3knows the team · via London Business School

×2knows the team · via Imperial College London

knows the team · via University of Oxford

✨ Fox Verdict

Investment thesis

UKI2S backs early-stage, ambitious businesses and university/research spinouts across the UK, providing capital and hands-on support from pre-seed through exit. With a 20-year track record, it helps portfolio companies raise further funding, recruit senior talent, build boards, advance DE&I and ESG, and deliver impact. The fund emphasizes co-investment, attracting roughly £25 of private capital for every £1 it invests, and leverages the broader Future Planet Capital network to help science- and technology-driven companies grow and scale.

Invests inAdvanced Manufacturing Biotech Cleantech Climate Tech Deep Tech Defense Tech EdTech Energy Hardware Healthtech Impact & Social Good IoT Medical Devices SaaSSector AgnosticSpace Tech Global London Manchester United Kingdom

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

Check

$127K – $635K

London, GB

Instruments

Equity

Founded

2001

AUM

$187.5M

Tracked investments

Team · 24 people

from the firm's website & curated & public directories

Alex Leigh· Investment Director Defence & Security· London, England, United Kingdomin

Managing Director for UK2IS with over 9 years of investment experience across deep tech VC and PE. Holds a BEng in Mechatronics and an MBA.

a•••@futureplanetcapital.comreveal

Hassan Mahmudul· Investment Manager· London, England, United Kingdomin

Works on Future Planet's UKI2S fund. Previously founded two startups and worked as a scout for Ada Ventures.

Oliver Sexton· Investment Director, Engineering Biology· London, England, United Kingdomin

Investment Director and Investment Committee member for the UK Innovation & Science Seed Fund with fifteen years of deep tech VC experience specialising in life sciences.

Sakura Holloway· Investment Director, Knowledge Assets· Oxford, England, United Kingdomin

Investment and commercialisation specialist who previously served as Head of Asset Portfolio at the University of Manchester Innovation Factory.

Shruti Iyengar· Investment Director· United Kingdomin

Supports the UK Innovation and Science Seed Fund. Previously an investor at Sustainable Ventures where she managed a 36-company portfolio and built their impact measurement practice.

Andrew Muir· Investment Director Seed and Fund Principal· Greater Guildford Area, United Kingdomin

Dr. Andrew Muir is Head of Seed Investments at Future Planet Capital and fund principal for UKI2S, and co-manages the Stephenson Fund and Blue Ocean Fund. He previously held roles at Zeneca, Biocompatibles, a US medical disinfection start-up, and NESTA, and holds a Chemistry degree and PhD from the University of Oxford.

a•••@futureplanetcapital.comreveal

Mark White· Investment Director, Fusion· Chilton, England, United Kingdomin

Mark White is Investment Director and Investment Committee member of UKI2S, having joined Midven in 2006. He has over twenty years of investment experience across UK investment banking and emerging markets, previously led NESTA's investment operations, and holds an MBA from London Business School.

m•••@futureplanetcapital.comreveal

Alison Campbell· Dr Alison Campbell OBE· United Kingdomin

Alison Campbell became CEO of the Government Office for Technology Transfer (GOTT) in April 2022. She previously spent over eight years as Director of Knowledge Transfer Ireland, and earlier held roles including interim CEO of the Medical Research Council's technology transfer company (MRCT) and led technology transfer and research support at King's College London, having begun her career in the biotech industry. She has chaired the board of AUTM, co-founded and chaired ATTP, was a founding Director of Praxis (now PraxisAuril), and was awarded an OBE in 2010.

Betty Bonnardel· Space Advisor

Betty Bonnardel is the CEO and founder of AB5 Consulting, a B Corp certified firm working on projects in space, satellite, nuclear, and energy. She also founded Farmer Charlie, a platform focused on farming in remote areas of Africa. She holds two Master's degrees in aeronautical and space engineering and an MBA, and has worked with organizations including NASA, ESA, the UK Space Agency, and UN agencies. She joined UKI2S as a Space Advisor.

Dr Colin Story· Advisory Board Member

Colin Story joined UKI2S as an advisory board member in November 2023 and has a background in business development within engineering biology organisations. He started his career at GE Healthcare in product development and project management before moving to Isis Innovation, where he built a business development team managing over 200 medical science innovations from Oxford University, and later served as Operations Director at OrganOx. He co-founded OxSonics in 2013 and was its CEO from 2014 to 2022, raising £25m across three rounds.

Dr Peter Hamley· Advisory Board Member

Dr Peter Hamley is an Advisory Board Member at UKI2S with a career in the biotech industry. He began at AstraZeneca after completing a PhD at Cambridge University, postdoctoral studies at the University of Pennsylvania, and an MBA from the University of Bath, and later spent more than a decade at Sanofi in drug discovery leadership and development roles. He currently serves as CSO of Samsara Therapeutics, which works on autophagy therapeutics, and has authored more than 60 patents, papers and book chapters.

Eddie Alleyn· Greater Oxford Areain

Eddie Alleyn spent thirty-five years in UK Government service across defence, security and foreign affairs. From 2011 to the end of 2016 he was Chair and CEO of HMGCC, a part of the FCDO focused on engineering, manufacturing and integrating secure communications and other technology systems for Government. Since then he has held Non-Executive and Advisory roles supporting British deep tech start-ups and scale-ups, particularly in London and Oxford, and is a Fellow of the IET.

John Patterson· United Kingdomin

John Patterson is a former Army officer whose final role was as a board member and executive director overseeing a £3.5bn per annum portfolio spanning information systems; intelligence, surveillance and reconnaissance; and medical technology. He was a founding member of the oversight board for the jHub, Strategic Command's innovation platform. He advises technology companies working in artificial intelligence and data analytics, engineering, medical technology, space, surveillance and uncrewed systems.

John Tingay· CTO of Paragraf· Greater Cambridge Areain

John Tingay is the CTO of Paragraf and has more than two decades of experience developing capital equipment for the semiconductor and electronics industries, spanning front-end semiconductor processes through wafer-level packaging. He has held non-executive roles at high-technology companies in the semiconductor and advanced imaging markets, and began his career in consulting engineering, later working on systems for particle accelerators and synchrotron physics.

Marcel Gehrung

Marcel Gehrung started his career in medical sciences and earned a PhD in Machine Learning in Healthcare from the University of Cambridge. He is CEO and co-founder of Cyted, a company focused on improving access to digestive health diagnostics for cancer and inflammatory diseases. His work has been recognized with a Forbes 30 under 30 listing and the Alexander Fleming Prize from the Bill & Melinda Gates Foundation.

Massimo Noro· Director (STFC), representing UKRI-Science & Technology Facilities Council as Special Partner in UKI2S· Daresbury Campusin

Dr Massimo Noro represents UKRI's Science & Technology Facilities Council (STFC) as the Special Partner in UKI2S. In 2018 he was appointed STFC Director for Business Development at the Daresbury Campus, where he leads business development, incubation programmes and support for early-stage deep-tech companies. He previously held global R&D roles at Unilever and holds a PhD in physical chemistry from UCLA, with published work in soft matter and self-assembling systems.

Nicholas Barsby· Chief of Staff, Defence and Security Accelerator (DASA)

Nicholas Barsby is Chief of Staff for the Defence and Security Accelerator (DASA), where he oversees programme management, budgeting, performance reporting, and communications. He previously served as a logistics officer in the Army and as a Senior Military Advisor at the Defence Science Technology Laboratory, and earlier managed a Government Major Projects Portfolio (GMPP) programme.

Nick Bassett· Associate Director of Innovation at the Biotechnology and Biological Sciences Research Council (BBSRC)· Gloucester, England, United Kingdomin

Nick Bassett is Associate Director of Innovation at the BBSRC, where he leads work to strengthen the UK bio-innovation ecosystem and link scientific research with commercial investment, covering biotechnology R&D programmes, the BBSRC Campus network, and enterprise initiatives. He previously developed Innovate UK's Investor Partnerships programme, supported the case for further investment in the Biomedical Catalyst, and co-founded an immunohistochemical screening company. He spent over 15 years in the medical devices sector focusing on diagnostics development.

Ruth Elliot· Advisory Board Member· New York, New York, United States

Ruth Elliot trained as an accountant with Deloitte and subsequently held roles in central government focused on corporate services, systems implementation, and financial control. She served as Deputy CFO at UK Research and Innovation, overseeing a budget of over £7bn, and later became Chief Financial Officer and Director of Corporate Services at the UK Atomic Energy Authority.

Sam Martin· Portfolio Director· London, England, United Kingdomin

Sam Martin previously worked at Seedrs, an equity crowdfunding platform, where he supported a sector-agnostic portfolio of over 700 early-stage startups on fundraising, corporate actions, and retail investor protections. He holds an Integrated Masters in International Relations and Global Issues from the University of Nottingham.

Thomas Storey· Senior Associate· Greater Guildford Area, United Kingdomin

Formerly a Principal Consultant at London Economics advising on strategic opportunities in the space sector.

Tim Irish· Sevenhampton, England, United Kingdomin

Tim Irish has spent 35 years in the life sciences industry, holding senior executive positions at health technology companies across Europe and North America, including GSK, GE, and Philips. He is a Professor of Practice at King's College London and previously served nearly seven years as Vice-Chair of the National Institute for Health and Care Excellence. He currently holds several non-executive board roles at health and digital technology companies in the UK, Europe, and the USA.

t•••@meridianhealthventures.comreveal

Tony Raven· Chair of Board and Consultation Committee· United Kingdomin

Tony Raven is a researcher and entrepreneur focused on university research commercialisation and venture investment. He served as CEO of Cambridge Enterprise, the University of Cambridge's commercialisation arm, for ten years until 2021, and founded Cambridge Innovation Capital and co-founded TenU, a partnership of university technology transfer offices. Earlier he was at the University of Southampton, where he co-created IP Group and helped establish the SETsquared incubator partnership, and previously founded three start-ups and conducted research at Oxford and Osaka Universities.

Ed Phillips· Investment Committee· Londonin

Founding team member and origination lead, investing as a partner from the flagship Future Planet Fund, Blue Ocean and Challenge Response strategies. Previously researched molecular genetics at HKU and holds a BSc in Biology from Bristol.

e•••@futureplanetcapital.comreveal

What they invest in

from 65 of 87 portfolio companies

Deep Tech ×40Biotech ×30AI & Machine Learning ×19Hardware ×13Healthtech ×11AgTech ×9Cleantech ×9New Materials ×9

HQs:United Kingdom×48Ireland×1

Who they back

founder profiles across 39 portfolio companies

54%

solo founders

21 of 39 mapped founding teams

15%

repeat founders

of 33 founders with career history

Founding team size:solo founder×212 founders×113 founders×64+ founders×1

Where their founders studiedfrom 28 founders with education data

University of York ×3Loughborough University ×2The University of Edinburgh ×2University College Dublin ×2University of Aberdeen ×2University of Bath ×2University of Nottingham ×2University of Oxford ×2

What their founders studiedfrom 35 founders with field-of-study data

Engineering ×11Life Sciences ×11Mathematics & Statistics ×5Physics ×3Computer Science ×2Economics ×2Medicine ×2

Where their founders worked beforefrom 33 founders with career history

University of Oxford ×5GSK ×3UCL ×3INVISTA ×2Rolls-Royce ×2The Alan Turing Institute ×2The University of Sheffield ×2University of Bristol ×2

23 founders hold a PhD · 2 hold an MBA (of 36 with degree data)

Investments · 87 tracked

founders shown can be your intro path

OxCan (Oxford Cancer Analytics)oxcan.org in✓ verified

Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making.

AI & Machine LearningBiotechMedical DevicesOxford, GB

Andreas Halner(Founder and Head of Healthcare AI)in Heinrich Roder(Chief Technology Officer)inDaniel Szulc(Chief Product Officer)in

Co-investorsEka Ventures Cross-Border Impact Ventures Meridian Health Ventures Civilization Ventures Management, Llc DigitalDx Ventures Onstage +1 more

Keitkeit.co.uk in 𝕏✓ verified

Keit is a technology hardware company founded in 2013 as a spin-out from the Science and Technology Facilities Council and European Space Agency Business Incubation Centre, developing new technology for established industries.

Advanced ManufacturingDeep TechHardwareOxfordshire, GB

Co-investorsWren Capital Future Planet Capital

Adamo Foods Seedadamofoods.com in 𝕏

Adamo Foods develops meat alternatives using a proprietary fermentation technology, producing fungi-based (mycelium) steaks and fillets.

BiotechDeep TechFoodTech

Pierre Dupuis(Founder)in

Co-investorsFuture Planet Capital

Antiverse Seedantiverse.io in 𝕏

Antiverse is a techbio company that uses machine learning and cell line engineering to design de novo antibody therapeutics against difficult targets such as G-protein coupled receptors and ion channels.

AI & Machine LearningBiotechDeep TechCardiff, GB

Ben H.(Founder)in

Co-investorsCambridge Angels group Deep Science Ventures DOMiNO Ventures Future Planet Capital Innospark Ventures

Aquark Technologies Seedaquarktechnologies.com in

AQuark Technologies develops miniaturised quantum hardware based on cold-atom sensing and timing technologies, using expertise in vacuum engineering, micro-fabrication, and photonics.

Deep TechHardwareQuantum ComputingSouthampton, GB

Andrei Dragomir(Founder)in

Co-investorsFuture Planet Capital

ArkVax Seedarkvax.com

ArkVax develops glycoconjugate vaccines for animal health using genetic engineering of bacterial cells, aiming to provide broader protection than current vaccines.

AgTechBiotechHealthtech

Jon Cuccui(Founder)in

Co-investorsFuture Planet Capital

Ascension Unkownascension.global in

Ascension develops technology related to the extraction or supply of critical materials used in applications such as magnets for wind turbines, solar panel coatings, speakers, displays, and batteries.

CleantechDeep TechNew Materials

Jonathan Blundy(Co-founder)Mike Kendall(Co-founder)Motoaki Sumi(Co-founder)in

Co-investorsFuture Planet Capital

Astut Seedastut.co.uk

Astut develops a hybrid AI system for supporting high stakes unseen decisions (HSUD), where organisations face one-off, irrevocable strategic choices with no prior outcomes to learn from.

AI & Machine LearningDeep TechEnterprise Software

Pete Grindrod(CEO)Sharon Whiteside(Head of Data & Analytics, CTO)

Co-investorsFuture Planet Capital Sure Valley Ventures

Atelerix Seedatelerix.co.uk in 𝕏

Atelerix develops hypothermic hydrogel encapsulation technology that stabilises and preserves fresh cells, tissues, and blood at room temperature, eliminating the need for cryopreservation and cold-chain logistics.

BiotechMedical DevicesNew Materials

Steve Swioklo(Founder)in

Co-investorsCambridge Angels group Future Planet Capital O2h Ventures

Atheras Analytics Seedatherasanalytics.com in

Atheras Analytics develops software tools for satellite operators to optimize the design and operation of high-throughput satellite networks that deliver broadband services globally.

AI & Machine LearningDeep TechSaaSSpace Tech

John Yates(Chairman of the Board, Co-founder)Dr. Charilaos Kourogiorgas(Director, Co-founder)James Youdale(President)inDr. Hector Fenech(Director)

Co-investorsFuture Planet Capital

Bitrobius Genetics Seedbitrobius.com in

Bitrobius develops gene therapy technologies, specifically the Gentrafix platform, leveraging microbial molecular biology and genetic engineering.

BiotechDeep TechHealthtech

Dr Rocky Cranenburgh(Founder)

Co-investorsFuture Planet Capital

CamGene Therapeuticscamgenetx.com in

CamGene Therapeutics develops RNA-based medicines, including mRNA, siRNA, and antisense oligonucleotides delivered via lipid nanoparticles, to treat the underlying cellular dysfunction that causes hearing loss.

BiotechDeep TechHealthtechCambridge, GB

Arpan Desai(CEO & Co-founder)inPrashant Shah(Co-founder)Sunil Shah(Co-founder)

Co-investorsCambridge Angels group Eos Advisory Future Planet Capital

Cryogenx Seedcryogenx.com in

Cryogenx develops CGX1, a portable body cooling device designed to treat heatstroke and prevent heat-related deaths.

BiotechDeep TechHardwareHealthtechMedical Devices

Matthew Power

BoardLevison Wood

Co-investorsBritish Design Fund Future Planet Capital

Cytotrait Managed by: Hassan Mahmudulcytotrait.com in

Cytotrait develops genetic technologies for crop improvement through chloroplast engineering.

AgTechBiotechManchester, GB

Junwei Ji(Co-Founder & Executive Director)inAnil Day(Co-founder & Scientific Advisor)Tim Brears(Executive Chair)in

Co-investorsNorthern Gritstone

digiLab Managed by: Mark Whitedigilab.ai in

digiLab provides an AI platform called the Uncertainty Engine that helps organizations and governments tackle complex, high-stakes challenges by combining machine learning with uncertainty quantification for safer, more explainable decision-making.

AI & Machine LearningDeep TechEnterprise Software

Prof. Tim Dodwell(Co-Founder & CEO)in Dr. Anhad Sandhu(Co-Founder & GM Saudi)in Dr. Andrew Corbett(Director of AI)inRory Scott Russell(Chief Growth Officer)in

BoardDr. Nigel Toon(Chairman)in

ExactTrak Seedexacttrak.com in

ExactTrak builds SmartSafe, embedded security technology that operates outside the operating system and BIOS to protect devices and data from cyber threats, tampering and human error.

CybersecurityHardwareIoT

Norman Shaw(Founder)in

Co-investorsFuture Planet Capital

Fusion Energy Partners Seedfusionenergypartners.com

Fusion Energy Partners provides engineering and technical consulting services to fusion energy research projects and organizations, drawing on deep expertise in fusion system design, construction, operation, and decommissioning.

CleantechDeep TechEnergyCulham, GB

Chris(Managing Director)Martin(Technical Director)

Co-investorsFuture Planet Capital

Halo X Ray Technologieshaloxray.com in

HALO develops real-time X-ray diffraction technology for automatic materials identification across aviation security, medical systems, and industrial applications.

Deep TechDefense TechGovTechHardware

Co-investorsFuture Planet Capital

Helix Geospacehelixgeospace.com in

Helix Geospace designs and manufactures compact, high-performance antennas for satellite navigation and communications using proprietary Dielectrix technology.

Deep TechDefense TechHardwareSpace TechAbingdon, GB

Oliver Leisten(Founder)in

Co-investorsBloc Ventures Future Planet Capital

Hexigonehexigone.com in

Hexigone develops corrosion-inhibition technology through its Intelli-ion "smart-release" platform (including the bio-based PX1 series) used in protective coatings, supplying coatings manufacturers with lower-carbon, safer inhibitors at over 800 MT per year.

Advanced ManufacturingCleantechNew MaterialsSwansea, GB

Patrick Dodds(Founder)in

Co-investorsOxford Investment Opportunity Network (OION)Sunnybarn Investments Development Bank of Wales Future Planet Capital

HonuWorxhonu-x.com in

HonuWorx develops uncrewed subsea robotics and communications platforms to replace surface vessels in offshore operations, serving oil and gas, offshore wind, and defence sectors.

Deep TechDefense TechEnergyRoboticsAberdeen, GB

Lee Wilson(Co-founder)inLucas Wissmann(Co-founder)in Callum Crawford(Head of Programmes)in

BoardSteven Gray(Chairman)

Co-investorsScottish Enterprise Future Planet Capital TRICAPITAL Vala Capital

HotHouse Therapeutics Seedhothousetx.com in

HotHouse Therapeutics uses artificial intelligence and synthetic biology to reprogram plant biosynthetic pathways to create novel pharmaceutical compounds not achievable through traditional chemical synthesis.

AI & Machine LearningBiotechDeep TechNorwich, GB

Professor Anne Osbourn OBE FRS FLS(Chief Science Officer)Dr David Sheppard(Chief Executive Officer)

Co-investorsCambridge Angels group Future Planet Capital Twin Path Ventures

HutanBio Seedhutanbio.com in

HutanBio develops marine microalgae-derived biofuels for decarbonizing heavy transport, using industrial-scale production platforms deployed on non-arable land without freshwater consumption.

BiotechCleantechClimate TechEnergyLondon, GB

Dr. John Archer(Founder and CSO)Dr. Noor Azlin Mokhtar(Founder & MD (Asia))Manshu Agarwal(CEO)

Co-investorsFuture Planet Capital

HydRegen Seedhydregenoxford.com in 𝕏

Hydregen develops biocatalysis platform technologies that integrate into existing chemical manufacturing infrastructure, aiming to cut process costs by 40-50% while lowering energy use and carbon emissions.

BiotechCleantechNew Materials

Co-investorsFuture Planet Capital Oxford Investment Opportunity Network (OION)Oxford Technology Management

iFASTifastdiagnostics.com in

iFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process.

BiotechHealthtechMedical DevicesWhiteley, GB

Toby King(CEO)in

Co-investorsMeridian Health Ventures Cambridge Capital Group Innovate UK Raw Ventures Future Planet Capital

IGS Seedigsint.com in 𝕏

International Geoscience Services provides specialized geodata collection, compilation, and interpretation services to support mineral exploration for governments, development agencies, and industry.

AgTechData & InfrastructureDeep TechEnergyEnterprise SoftwareGovTech

Garth Earls(Director)Mark Parker(Director)in

Co-investorsFuture Planet Capital

Ikarovec Seedikarovec.com in

Ikarovec is a biotech company focused on developing treatments for retinal diseases affecting vision.

BiotechDeep TechDigital HealthHealthtechMedical DevicesNorwich, GB

Peter Widdowson, PhD(Scientific Founder)Thomas Ciulla, M.D, MBA(President and Chief Executive Officer)in

Co-investorsLifeArc Ventures Future Planet Capital

Inition Seedinition.energy

이명열(Founder)Boris G.(Founder)in

Co-investorsFuture Planet Capital

Laverock Therapeutics Seedlaverocktx.com in

Laverock Tx is a biotechnology company working in the gene therapy and gene editing space, with a leadership and advisory team drawn from cell and gene therapy, immunology, and life-science investing backgrounds.

BiotechDeep TechHealthtech

Co-investorsCalculus Capital Ltd.Eos Advisory Future Planet Capital Tekfen Ventures

Lineat Seedlineat.co.uk in

Lineat develops advanced fibre-forming technology (AFFT) for manufacturing recycled carbon fibre products, including sporting equipment.

Advanced ManufacturingCircular EconomyDeep TechNew MaterialsBristol, GB

Dr. Lourens Blok(CTO, Co-founder)Gary Owen(CEO)inLuis Cunha(Director of Engineering)in

Co-investorsFuture Planet Capital One Planet Capital Oxford Investment Opportunity Network (OION)

Luffy AI Seedluffy.ai in

Luffy AI develops neuroplastic AI controllers that provide a real-time adaptive control layer for physical systems, running on existing on-board hardware.

AI & Machine LearningDeep TechRobotics

Alex Meakins(Founder)in

Co-investorsBow Capital Chrysalix Future Planet Capital Momenta Ventures

Machine Discovery Seedmach42.ai in

Mach42 offers a cloud-based platform that uses neural networks to accelerate simulation and design optimization across complex engineering problems.

AI & Machine LearningDeep TechSaaSSemiconductors

Bijan Kiani(CEO)in

Co-investorsFuture Planet Capital Foresight Group

Messium Seedmessium.co.uk

Messium uses satellite hyperspectral imaging (160 wavelengths at 5m resolution) and AI trained on lab samples to measure crop nitrogen levels and generate variable-rate fertiliser application maps.

AgTechAI & Machine LearningSpace TechLondon, GB

George Gilks(CEO & Co-founder)in Vishal Soomaney Vijaykumar(CTO & Co-founder)in

Co-investorsEntrepreneur First Expansion Ventures Future Planet Capital Newland Syndicate SuperSeed

MitoRx Therapeuticsmitorxtherapeutics.com in

MitoRx is a preclinical-stage biotech developing MTRX31, a first-in-class small molecule that restores mitochondrial metabolism to eliminate ectopic fat in patients with metabolically unhealthy, high-risk obesity.

BiotechLongevity

Jon R.(Founder)in

Co-investorsFuture Planet Capital Oxford Investment Opportunity Network (OION)Oxford Technology Management Wren Capital

NKIO Seednk-io.com

NK:IO develops natural killer (NK) cell and small molecule therapies for cancer, targeting both haematological and solid tumours such as ovarian cancer.

BiotechDeep TechHealthtechLondon, GB

Hugh Brady(Co-founder)Matthew J. Fuchter(Co-founder)Andrew Baxendale in

Co-investorsCambridge Angels group Future Planet Capital

Northrownorthrow.com in 𝕏

ID-Pal provides AI-powered online identity verification and AML screening for businesses to meet KYC and KYB compliance requirements.

AI & Machine LearningCybersecurityEnterprise SoftwareFintechSaaSDublin, IE

Colum Lyons(CEO and Founder)inJames O'Toole(Chief Business Officer)Robert O'Farrell(Chief Technology Officer)in

Co-investorsBayes Entrepreneurship Fund Future Planet Capital Perscitus LLP QVentures

Opteraoptera.uk

Optera develops bio-inspired, event-based vision sensors and neuromorphic semiconductor chips paired with on-source processing algorithms to provide situational awareness in space and defence environments.

Deep TechDefense TechSemiconductorsSpace Tech

Co-investorsBlackfinch Ventures Empirical Ventures Foresight Foresight Group Future Planet Capital

Oxford Space Systems - companyoxford.space

Oxford Space Systems designs and manufactures deployable antennas for satellites, focused on reducing mass and improving stowage efficiency and performance.

Deep TechHardwareSpace TechHarwell, GB

Sean Sutcliffe in

Co-investorsCambridge Angels group EMV Capital Future Planet Capital Longwall Venture Partners LLP Martlet Capital Oxford Investment Opportunity Network +4 more

Pencil Biosciences - companypencilbiosciences.com in

Pencil Biosciences develops a fully synthetic, modular, non-CRISPR gene editing platform that edits DNA without causing a break or nick.

BiotechDeep TechHealthtech

Co-investorsEMV Capital Future Planet Capital Martlet Capital Northern Gritstone Octopus Ventures

ProductiveMachines Seedproductivemachines.co.uk in

Productive Machines develops software, including its SenseNC product and stability-map technology, that optimizes CNC machine tool settings and toolpaths to eliminate chatter vibrations, improving part quality, productivity, and tool life.

Advanced ManufacturingAI & Machine LearningSaaSRotherham, GB

Erdem Ozturk(Founder & CEO)inDr Huseyin Celikag(CTO & Co-founder)

Co-investorsACT Venture Partners Future Planet Capital Fuel Ventures

Q5D Managed by: Mark Whiteq5d.com in

Q5D develops automated wiring solutions for manufacturing, addressing labour shortages and enabling electrification in automotive and industrial sectors.

Advanced ManufacturingHardwareRoboticsPortishead, Bristol, GB

Stephen Bennington(CEO)Chris Elsworthy(CTO)inRachel Eggington(COO)in Janet Donovan(CFO)in Simon Baggott(CMO)in

Co-investorsChrysalix UntroD Capital Lockheed Martin Ventures

Qdot Technology Seedqdot.tech in 𝕏

Qdot develops custom aerothermal and thermal management technologies, including heat exchangers, battery packs, and hybrid propulsion systems, using additive manufacturing and AI-driven design.

CleantechDeep TechHardware

Jack Nicholas(Co-founder)in Holt Wong(Co-founder)in Peter Ireland(Co-founder)in

Co-investorsEast Innovate Future Planet Capital Oxford Investment Opportunity Network (OION)

Quantum Dice Seedquantum-dice.com in

Quantum Dice develops a scalable probabilistic computing platform using quantum photonic technology to address energy-intensive AI models and complex industrial optimization problems.

AI & Machine LearningDeep TechQuantum ComputingOxford, GB

Co-investorsA15 Future Planet Capital Elaia

QuberTechqubertech.uk in

QuberTech is a UK-based biotechnology company developing biotech tools to produce natural rubber from alternative crops grown in controlled environments, aiming to deliver traceable and sustainable materials.

AgTechBiotechNew Materials

Co-investorsSustainable Ventures Future Planet Capital

Resurrect Bioresurrect.bio in

Resurrect Bio develops genetic disease-resistance traits for crops by restoring plant R-genes, using its FloraFold AI platform and rapid in-planta screening for trait discovery.

AgTechAI & Machine LearningBiotech

Cian Duggan(CEO / Co-Founder)inTolga Bozkurt(Co-Founder)inSophien Kamoun(Co-Founder)

Co-investorsCalculus Capital Ltd.Future Planet Capital SynBioVen AgFunder Pymwymic

Revolver Therapeutics Managed by: Oliver Sextonbath.ac.uk in

Bath, GB

Revona Bio Managed by: Hassan Mahmudulrevona.bio in

Biotech

Sention Technologies Seedsention.io

Sention Technologies provides measurement and data solutions for battery development and manufacturing, using ultrasound, X-ray computed tomography, and electrochemical testing combined with AI to improve battery quality, efficiency, and safety.

AI & Machine LearningDeep TechEnergyLondon, GB

Co-investorsEndgame Capital Future Planet Capital Twin Path Ventures Third Sphere

Silicon Microgravitysilicong.com

SMG develops high-precision resonant MEMS inertial and gravity sensors, including accelerometers, gyroscopes, and the GAIA gravity system, spun out from Cambridge University research.

Deep TechDefense TechHardwareCambridge, GB

Ashwin Seshia(Professor (technology originator))

Co-investorsFuture Planet Capital

Silveray Seedsilveray.co.uk in

Silveray develops flexible X-ray detectors using patented semiconductor ink technology for non-destructive testing in industrial applications including oil and gas, nuclear energy, aerospace, and shipbuilding.

Advanced ManufacturingDeep TechHardwareStockport, GB

Co-investorsCambridge Angels group Future Planet Capital Northern Gritstone

Smarter Naturally Seedsmarternaturally.com

BrocStar sells a patented "super-broccoli" high in sulforaphane, offered as a once-weekly soup, a raw powder supplement, and dark chocolate-coated snacks aimed at supporting metabolic health.

ConsumerFoodTechWellness & Fitness

Co-investorsFuture Planet Capital

Solasta Biosolastabio.com in

SOLASTA Bio develops peptide-based, precision-targeted biological insecticides that control specific pest insects while remaining non-toxic to non-target species such as pollinators, wildlife and humans.

AgTechBiotechCleantech

Shireen Davies(CEO)in

Co-investorsCarbon Cavallo Ventures Future Planet Capital The Yield Lab The Yield Lab Europe

Sona Managed by: Sakura Hollowaynpl.co.uk in 𝕏

NPL is a national measurement institute providing measurement science expertise and facilities to government, research organizations, and industries across the UK.

Data & InfrastructureDeep TechDeveloper ToolsEnterprise SoftwareGovTechQuantum ComputingTeddington, GB

Spaceflux Seedspaceflux.io in

Spaceflux operates a global optical sensor network for space situational awareness, providing orbital tracking data (LEO to GEO), AI-driven analytics, and hardware nodes for civil and defence customers.

AI & Machine LearningDeep TechDefense TechSpace TechLondon, GB

Dr Marco Rocchetto(Chief Executive Officer & Co-Founder)Marcel Debczynski(Chief Commercial Officer & Co-Founder)in Prof. Ingo Waldmann(Chief Technology Officer & Co-Founder)inDr Robert Simpson(Chief Product Officer)inSimon Edrich(Chief Financial Officer)inJohn Cook(Chief Operating Officer)

Co-investorsBlackfinch Ventures Foresight Group Future Planet Capital Seraphim Space

Spotlight Pathologyspotlightpathology.com in

Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Martin(Co-Founder and Chief Technology Officer)Richard(Co-Founder and Chief Medical Officer)Sam Perona (Westgate)(Chief Executive Officer)in

Co-investorsDeepbridge Capital Future Planet Capital River Capital

SugarOx Seedsugarox.co.uk in

SugaROx develops precision crop biostimulants using patented chemical-caging technology to deliver single-molecule formulations that improve plant metabolism and stress responses, targeting staple crops including wheat, barley, soybean, and maize for agricultural markets.

AgTechBiotechClimate TechUnited Kingdom, GB

BoardMark Robbins

Co-investorsFuture Planet Capital

Surrey H2 Funding Raisedsurreyh2.com

Surrey Hydrogen develops green hydrogen production technology.

CleantechClimate TechEnergyNew MaterialsDidcot, GB

Dr Bahman Amini Horri(Founder & Advisor)Dakota Johnston(CEO & Founder)

Co-investorsFuture Planet Capital Oxford Technology Management

Synthacesynthace.com in 𝕏

Synthace provides a software platform for experimental design and lab automation, enabling researchers to run Design of Experiments (DOE) workflows across multiple automated laboratory instruments and devices.

AI & Machine LearningBiotechCloud ComputingDeep TechSaaS

Markus Gershater, PhD(Chief Executive Officer & Co-Founder)

Co-investors11.2 Capital Future Planet Capital Horizons Ventures Sofinnova Partners Amadeus Capital Partners SOSV

Ternary Tx Managed by: Oliver Sextonternarytx.co.uk

Ternary develops AI-driven drug discovery technology focused on targeted protein degradation and induced proximity platforms.

AI & Machine LearningBiotechDeep Tech

Chris Tame(CEO & Co-Founder)in Andrew Potterton(CTO & Co-Founder)in

Co-investorsPace Ventures

The Electrospinning Companyelectrospinning.co.uk in

Electrospinning is a materials technology company that manufactures electrospun products, with a focus on sustainable operations and rigorous safety standards for both patients and workers.

Advanced ManufacturingBiotechMedical DevicesNew MaterialsUK, GB

Ann Kramer(CEO)inRob McKean(COO)in

Co-investorsFuture Planet Capital

Tokamak Energy Managed by: Mark Whitetokamakenergy.com

Tokamak Energy develops fusion energy technology, working toward commercial fusion power as part of the transition to net zero.

CleantechDeep TechEnergy

Tropic Biosciencestropic.bio in

Tropic develops improved varieties of tropical crops using gene editing and gene silencing technologies to enhance yield, disease resistance, and climate resilience.

AgTechBiotechNorwich, GB

Co-investorsAgronomics Aliment Capital Bloom8 Blue Horizon Corporation Canaan Partners Carbon +7 more

Twig Biotwig.bio in

Twig uses artificial intelligence and biology to design novel microbes for ingredient production.

AI & Machine LearningBiotechDeep TechLondon, GB

James Allen(Co-Founder & CSO)in Satnam Surae(Co-Founder & CTO)inRuss Tucker(Co-Founder & CEO)in

Co-investorsFuture Planet Capital Project A Ventures

Vector Photonicsvectorphotonics.co.uk in

Vector Photonics develops PCSELs (photonic crystal surface-emitting lasers), a type of semiconductor surface-emitting laser designed to be lower cost and easier to integrate than conventional lasers.

Deep TechHardwareSemiconductorsGlasgow, GB

Dr Richard J E Taylor(Founder)in

Co-investorsClean Growth Fund Equity Gap Future Planet Capital Foresight Group

Vitarka Therapeuticsvitarka.co.uk in

Vitarka Therapeutics develops ENDOPORE, a drug delivery technology designed to transport therapeutic molecules into cells to treat diseases including cancer.

BiotechHealthtechMedical Devices

Vineeta Tripathi(Founding CEO)in John Beadle(Co-founder)in

Co-investorsFuture Planet Capital SOSV

Wave Photonics Managed by: Mark Whitewavephotonics.com in 𝕏

Wave Photonics develops photonic component libraries and co-packaged optics intellectual property for licensing, including energy-efficient modulator designs and control circuits.

Deep TechHardwareSemiconductorsCambridge, GB

Mateusz Kubica(Founder)in

Co-investorsQAI Ventures

Zentraxa Seedzentraxa.com in 𝕏

Zentraxa precision-engineers bespoke bio-peptides and biomaterials, including adhesives inspired by marine mollusc chemistry that perform in wet, dirty and submerged conditions.

BiotechDeep TechNew Materials

Co-investorsFuture Planet Capital Oxford Investment Opportunity Network (OION)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

14 GlialignAstutdigiLabExactTrakFusion Energy PartnersHalo XrayHydRegenIGS (Geoscience International)InitionLineatLuffy AIMuWaveMycoNourish Managed by: Shruti IyengarPresymptom Health SeedQ5DQuantum DiceSentionSugarOxTokamak EnergyWave Photonics

Portfolio news

latest coverage across their companies

Glasgow University Spin-out Vector Photonics Looks to Taiwan to Industrialize Next-Generation Lasers

Vector Photonics · techsoda.substack.com · Aug 24, 2026

CamGene Therapeutics partners COSA for 3D printed ear model for hearing loss treatment

CamGene Therapeutics · cambridgeindependent.co.uk · Aug 20, 2026

Mach42 Raises £7M for AI Analog Circuit Simulation - Fundraise Insider

Machine Discovery Seed · fundraiseinsider.com · Jul 26, 2026

Cambridge semiconductor firm secures £6m boost - UKTN

Silicon Microgravity · uktech.news · Jul 17, 2026

How Singapore Fintech iFAST Became A Regional Wealth Engine

iFAST · forbes.com · Jul 10, 2026

Payload 🚀 on X: "Optera, an Australian startup developing sensors for SDA, announced £3M ($4M) in fresh funding to finance its relocation—with plans to move to the UK and attract new European customers. https://t.co/UX8ZgJnkaR" / X

Optera · x.com · Jun 17, 2026

MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth

MitoRx Therapeutics · globenewswire.com · Jun 9, 2026

From warships to wind farms: Hexigone lands £1.2m to tackle industrial corrosion – UKI2S

Hexigone · ukinnovationscienceseedfund.co.uk · Jun 9, 2026

Frequently asked questions

How many investments has UK Innovation & Science Seed Fund made?: UK Innovation & Science Seed Fund has 87 tracked investments.
What stage does UK Innovation & Science Seed Fund invest at?: UK Innovation & Science Seed Fund invests at the Pre-Seed, Seed, Series A stages.
What is UK Innovation & Science Seed Fund's typical check size?: UK Innovation & Science Seed Fund typically writes checks of $127K – $635K.
What sectors does UK Innovation & Science Seed Fund focus on?: UK Innovation & Science Seed Fund focuses on Advanced Manufacturing, Biotech, Cleantech, Climate Tech, Deep Tech, Defense Tech, EdTech, Energy, Hardware, Healthtech, Impact & Social Good, IoT, Medical Devices, SaaS, Sector Agnostic, Space Tech.
Where is UK Innovation & Science Seed Fund located?: UK Innovation & Science Seed Fund is headquartered in London, GB.
Who does UK Innovation & Science Seed Fund co-invest with?: UK Innovation & Science Seed Fund most often shares deals with Future Planet Capital, Cambridge Angels group, Oxford Investment Opportunity Network (OION), among 67 tracked co-investors.

Images

Similar investors

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.

$250K

BDC Fund Investments (Fund-of-Funds)

BDC Fund Investments is the fund-of-funds arm of BDC Capital that acts as a limited partner in venture and growth capital funds backing technology-focused Canadian companies. It supports emerging and established fund managers to strengthen Canada's innovation ecosystem.

UntroD Capital

UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.

$772K – $241M

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

$100K – $10M

Range VC

Range is a venture capital firm that invests in founders building novel solutions in overlooked or challenging categories. The firm focuses on consensus founders with unique insights, backing companies at various stages across diverse sectors.

$1M – $3M

Featured in lists

Investors & VC Firms in North America Investors & VC Firms in United States Seed Investors & VC Firms Series A Investors & VC Firms Pre-Seed Investors & VC Firms Seed Investors & VC Firms in North America Investors & VC Firms in Europe Seed Investors & VC Firms in United States Series A Investors & VC Firms in North America Series A Investors & VC Firms in United States Investors & VC Firms in Global SaaS Investors & VC Firms